Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Damaj

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
European Journal of Haematology|July 30, 2002
Severe cardiac toxicity after monoclonal antibody therapyG Damaj, M T Rubio, V Audard, et al.
Pharmacology|January 6, 2009
Drug rash with eosinophilia and systemic symptoms after chlorambucil treatment in chronic lymphocytic leukaemiaI Vaida, F Roszkiewicz, B Gruson, et al.
Cancer Epidemiology|November 21, 2022
Role of social status and social environment on net survival in patients with chronic lymphocytic leukemia: A high-resolution population-based studyB Delapierre, X Troussard, G Damaj, et al.
European Journal of Internal Medicine|February 24, 2006
Myelofibrosis and cytopenia are not always malignantB Gruson, M Brevet, I Vaida, et al.
European Journal of Haematology|September 9, 2005
First-line autologous stem cell transplantation in primary CNS lymphomaM Brevet, R Garidi, B Gruson, et al.
Bone Marrow Transplantation|September 1, 1999
Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipientsM Rosenzwajg, N Fery, V Bons, et al.
Leukemia|September 13, 2003
Thalidomide therapy induces response in relapsed mantle cell lymphomaG Damaj, F Lefrère, R Delarue, et al.
European Journal of Haematology|January 19, 2005
Single-agent thalidomide induces response in T-cell lymphomaG Damaj, R Bouabdallah, N Vey, et al.
Leukemia|April 27, 2007
Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumabB Royer, I Vaida, A Etienne, et al.
Intensive Care Medicine|July 1, 1995
Predicting infection in critically ill surgical patients: usefulness of bacteriuriaT A Bensousan, F Vincent, G Damaj, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|July 30, 2002
Severe cardiac toxicity after monoclonal antibody therapyG Damaj, M T Rubio, V Audard, et al.
Pharmacology|January 6, 2009
Drug rash with eosinophilia and systemic symptoms after chlorambucil treatment in chronic lymphocytic leukaemiaI Vaida, F Roszkiewicz, B Gruson, et al.
Cancer Epidemiology|November 21, 2022
Role of social status and social environment on net survival in patients with chronic lymphocytic leukemia: A high-resolution population-based studyB Delapierre, X Troussard, G Damaj, et al.
European Journal of Internal Medicine|February 24, 2006
Myelofibrosis and cytopenia are not always malignantB Gruson, M Brevet, I Vaida, et al.
European Journal of Haematology|September 9, 2005
First-line autologous stem cell transplantation in primary CNS lymphomaM Brevet, R Garidi, B Gruson, et al.
Bone Marrow Transplantation|September 1, 1999
Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipientsM Rosenzwajg, N Fery, V Bons, et al.
Leukemia|September 13, 2003
Thalidomide therapy induces response in relapsed mantle cell lymphomaG Damaj, F Lefrère, R Delarue, et al.
European Journal of Haematology|January 19, 2005
Single-agent thalidomide induces response in T-cell lymphomaG Damaj, R Bouabdallah, N Vey, et al.
Leukemia|April 27, 2007
Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumabB Royer, I Vaida, A Etienne, et al.
Intensive Care Medicine|July 1, 1995
Predicting infection in critically ill surgical patients: usefulness of bacteriuriaT A Bensousan, F Vincent, G Damaj, et al.
Pageof 6